NSE: DRREDDY · 8 October 2026 · Pre-market update
- Dr. Reddy's Laboratories is in focus ahead of the market open following an official announcement regarding its upcoming quarterly financial results. The company has slated its earnings call for October 23, 2026, to discuss its performance for the quarter and six months ended September 30, 2026. Market participants will watch the stock as it digests this calendar update alongside recent technical levels.
- Dr. Reddy's Laboratories announced that it will release its financial results for the quarter and six months ended September 30, 2026, on Friday, October 23, 2026, following a board meeting. Management will subsequently host an earnings call at 19:30 PM IST / 10:00 AM ET to discuss the financial performance with investors and analysts.
- Trading volume was 0.81 times the 20-day average daily volume.
Dr. Reddy S Laboratories Company News Before Market Open
Dr. Reddy's Laboratories is in focus ahead of the market open following an official announcement regarding its upcoming quarterly financial results. The company has slated its earnings call for October 23, 2026, to discuss its performance for the quarter and six months ended September 30, 2026. Market participants will watch the stock as it digests this calendar update alongside recent technical levels.
Upcoming financial results announcements often drive institutional positioning and sector-wide sentiment shifts. The scheduled earnings call provides a platform for management to address operational updates and performance drivers. Technical boundaries established during the prior session will frame initial trading ranges ahead of the announcement.
16.38 lakh shares traded on 6 October 2026. This compares with a 20-day average daily volume of 20.32 lakh shares (0.81 times). The five-day average daily volume was 30.11 lakh shares.
Upcoming financial results announcements often drive institutional positioning and sector-wide sentiment shifts. The scheduled earnings call provides a platform for management to address operational updates and performance drivers. Technical boundaries established during the prior session will frame initial trading ranges ahead of the announcement.
Latest Company Developments
Dr. Reddy's Laboratories announced that it will release its financial results for the quarter and six months ended September 30, 2026, on Friday, October 23, 2026, following a board meeting. Management will subsequently host an earnings call at 19:30 PM IST / 10:00 AM ET to discuss the financial performance with investors and analysts.
Setting an official date for the earnings release allows market participants to prepare for upcoming financial disclosures and performance metrics.
a press release dated October 07, 2026, titled "Intimation of Earnings call".
Ownership & Transaction Activity
Mutual Fund Holdings
Mutual funds held 13.16% on 30 June 2026. This compares with 13.19% on 31 March 2026, a change of -0.03 percentage points.
The filing reported 40 MF/UTI holders.
What to Watch Next
- Price action relative to the prior session's close of 1208.0 and the 20-day average close of 1190.76.
- Volume participation and order flow during the pre-market and opening trades following the earnings calendar notification.
- Support and resistance levels near the prior day's range between 1195.0 and 1212.7.
Other Dated Coverage
- Dr. Reddy S Laboratories Share Price Today: Why DRREDDY Is Falling 0.35% | 7 October 2026 — 7 October 2026
- Dr. Reddy's Shares Dip 0.27% Amid Pharma Sector Consolidation | 5 October 2026 — 5 October 2026
- Why Dr. Reddy's Shares Fell 2.75% Today | 1 October 2026 — 1 October 2026
More Dr. Reddy S Laboratories news and dated analysis →
Frequently Asked Questions
What is the latest Dr. Reddy S Laboratories company news?
Dr. Reddy's Laboratories announced that it will release its financial results for the quarter and six months ended September 30, 2026, on Friday, October 23, 2026, following a board meeting. Management will subsequently host an earnings call at 19:30 PM IST / 10:00 AM ET to discuss the financial performance with investors and analysts.
How strong was Dr. Reddy S Laboratories’s trading volume?
16.38 lakh shares traded, 0.81 times the 20-day average daily volume. The price and volume data are dated 6 October 2026.
Do the mutual-fund figures show buying today?
They show holdings on 30 June 2026. Quarterly holdings do not identify purchases made on the article date.
Research & analysis: WittyTrades Research Desk
Reviewed by: Mohanish Sanghavi — SEBI Registered Research Analyst
Disclaimer: Investments in securities markets are subject to market risks. Registration with SEBI and NISM certification do not guarantee performance or returns. This article is for information and education, not personalised investment advice or a recommendation to buy, sell or hold.